Heterogeneity in lung cancer
VML de Sousa, L Carvalho - Pathobiology, 2018 - karger.com
Lung cancer diagnosis is a challenge since it is also one of the most frequently diagnosed
cancers. Diagnostic challenges are deeply related to the development of personalized …
cancers. Diagnostic challenges are deeply related to the development of personalized …
Roles of fibroblast growth factor receptors in carcinogenesis
EM Haugsten, A Wiedlocha, S Olsnes… - Molecular cancer research, 2010 - AACR
The fibroblast growth factor receptors (FGFR) play essential roles both during development
and in the adult. Upon ligand binding, FGFRs induce intracellular signaling networks that …
and in the adult. Upon ligand binding, FGFRs induce intracellular signaling networks that …
Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC
H Terai, K Soejima, H Yasuda, S Nakayama… - Molecular cancer …, 2013 - AACR
Patients with non-small cell lung cancer (NSCLC) that harbors epidermal growth factor
receptor (EGFR) mutations initially respond to EGFR-tyrosine kinase inhibitors (TKI) but …
receptor (EGFR) mutations initially respond to EGFR-tyrosine kinase inhibitors (TKI) but …
Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma
AK Nagatsuma, M Aizawa, T Kuwata, T Doi, A Ohtsu… - Gastric cancer, 2015 - Springer
Background Some tyrosine kinase receptors (RTKs) play critical roles in gastric cancer
progression. Not only trastuzumab, but also several other agents targeting RTKs are being …
progression. Not only trastuzumab, but also several other agents targeting RTKs are being …
Protein arginine methyltransferase 5 is essential for growth of lung cancer cells
Z Gu, S Gao, F Zhang, Z Wang, W Ma… - Biochemical …, 2012 - portlandpress.com
PRMT5 (protein arginine methyltransferase 5) is an enzyme that catalyses transfer of methyl
groups from S-adenosyl methionine to the arginine residues of histones or non-histone …
groups from S-adenosyl methionine to the arginine residues of histones or non-histone …
A novel computational approach for drug repurposing using systems biology
Motivation Identification of novel therapeutic effects for existing US Food and Drug
Administration (FDA)-approved drugs, drug repurposing, is an approach aimed to …
Administration (FDA)-approved drugs, drug repurposing, is an approach aimed to …
[HTML][HTML] FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1
T Huang, L Wang, D Liu, P Li… - International …, 2017 - spandidos-publications.com
Abstract Fibroblast growth factor 7 (FGF7) is a mesenchyme-specific heparin-binding growth
factor that binds FGF receptor 2 (FGFR2) to regulate numerous cellular and physiological …
factor that binds FGF receptor 2 (FGFR2) to regulate numerous cellular and physiological …
PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
Despite improvement in our understanding of long noncoding RNAs (lncRNAs) role in
cancer, efforts to find clinically relevant cancer-associated lncRNAs are still lacking. Here …
cancer, efforts to find clinically relevant cancer-associated lncRNAs are still lacking. Here …
KrasG12D and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung
Y Maeda, T Tsuchiya, H Hao… - The Journal of …, 2012 - Am Soc Clin Investig
Mucinous adenocarcinoma of the lung is a subtype of highly invasive pulmonary tumors and
is associated with decreased or absent expression of the transcription factor NK2 homeobox …
is associated with decreased or absent expression of the transcription factor NK2 homeobox …
EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non–small cell lung carcinoma
C Behrens, LM Solis, H Lin, P Yuan, X Tang… - Clinical cancer …, 2013 - AACR
Purpose: Enhancer of zeste homolog 2 (EZH2) promotes carcinogenesis by epigenetically
silencing tumor suppressor genes. We studied EZH2 expression by immunohistochemistry …
silencing tumor suppressor genes. We studied EZH2 expression by immunohistochemistry …